Mutational analysis of the β-tubulin gene in lung cancer

Lung Cancer

Volumn 35, Issue 1, 2002, Pages 11-16

  Tsurutani, Junji ^a   Komiya, Takefumi ^a   Uejima, Hisao ^a   Tada, Hirohito ^b   Syunichi, Negoro ^b   Oka, Mikio ^c   Kohno, Shigeru ^c   Fukuoka, Masahiro ^a   Nakagawa, Kazuhiko ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY GENERAL HOSPITAL   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

Author keywords

Doxorubicin; Multidrug resistance (MDR); Non small cell lung cancer (NSCLC); Paclitaxel; Single nucleotide polymorphism (SNP); Small cell lung cancer (SCLC)

Indexed keywords

BETA TUBULIN; COMPLEMENTARY DNA; GUANINE NUCLEOTIDE; PACLITAXEL; RNA;

ARTICLE; BINDING SITE; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; GENETIC CODE; HUMAN; HUMAN CELL; JAPAN; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MICROTUBULE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SILENT GENE;

BIOPSY; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; DNA, NEOPLASM; HUMANS; LUNG NEOPLASMS; MUTATION; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUBULIN; TUMOR CELLS, CULTURED;

EID: 0036135980     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(01)00291-4     Document Type: Article

References (24)

1. Kettering Prize. P-glycoprotein and resistance to anticancer drugs
2. Mode of action of Taxol and characterization of a multidrug-resistant cell line resistant to Taxol
3. CHO mutants resistant to colchicine, colcemid or griseofulvin have an altered β-tubulin
4. A β-tubulin leucine cluster involved in microtubule assembly and paclitaxel resistance
5. Taxol-dependent mutants of Chinese hamster ovarian cells with alternations in α- and β-tubulin
6. Paclitaxel resistance in non-small-cell lung cancer associated with beta-tubulin gene mutations
7. Cyclophosphammide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
8. Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck
9. A gynecologic oncology group study
10. Paclitaxel plus carboplatin in advanced non-small-cell-lung-cancer: A Phase II trial
11. Paclitaxel-resistant human ovarian cancer cells have mutant β-tubulins that exhibit impaired paclitaxel-driven polymerization
12. K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer
13. Clinical significance of K-ras point mutations in advanced adenocarcinoma or large cell carcinoma of the lung
14. Diverse mechanisms in the generation of human beta-tubulin pseudogenes
15. Evidence that a human beta-tubulin pseudogene is derived from its corresponding mRNA
16. Identification of two human β-tubulin isotypes
17. Evolutionary history of a multigene family: An expressed human beta-tubulin gene and three processed pseudogenes
18. Antisense oligonucleotides to class III β-tubulin sensitize drug-resistant cells to Taxol
19. Preferential binding of E7010 to murine β3-tubulin and decreased β3-tubulin in E7010-resistant cell lines
20. Overexpression of class I, II or IV β-tubulin isotypes in CHO cells is insufficient to confer resistance to paclitaxel
21. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines
22. Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MESSA
23. Expression of a full-length cDNA for the human MDR1 gene confers resistance to colchicines, doxorubicin, and vinablastine
24. The direct activation of human multidrug resistance gene (MDR1) by anticancer agents